Clinical Trial Update: Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Acute Lung Injury [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating human umbilical cord–derived mesenchymal stem cell therapy for acute lung injury and acute respiratory distress syndrome; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy (mesenchymal stem cells (umbilical cord-derived))

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: Acute Lung Injury, Acute Respiratory Distress Syndrome | Phase 1, Phase 2 | Status: UNKNOWN